489 related articles for article (PubMed ID: 27477083)
1. Does the vaginal microbiota play a role in the development of cervical cancer?
Kyrgiou M; Mitra A; Moscicki AB
Transl Res; 2017 Jan; 179():168-182. PubMed ID: 27477083
[TBL] [Abstract][Full Text] [Related]
2. Cervical Squamous Intraepithelial Lesions Are Associated with Differences in the Vaginal Microbiota of Mexican Women.
Nieves-Ramírez ME; Partida-Rodríguez O; Moran P; Serrano-Vázquez A; Pérez-Juárez H; Pérez-Rodríguez ME; Arrieta MC; Ximénez-García C; Finlay BB
Microbiol Spectr; 2021 Oct; 9(2):e0014321. PubMed ID: 34643408
[TBL] [Abstract][Full Text] [Related]
3. The vaginal microbiota, human papillomavirus and cervical dysplasia: a systematic review and network meta-analysis.
Norenhag J; Du J; Olovsson M; Verstraelen H; Engstrand L; Brusselaers N
BJOG; 2020 Jan; 127(2):171-180. PubMed ID: 31237400
[TBL] [Abstract][Full Text] [Related]
4. Microbiome and Cervical Cancer.
Castanheira CP; Sallas ML; Nunes RAL; Lorenzi NPC; Termini L
Pathobiology; 2021; 88(2):187-197. PubMed ID: 33227782
[TBL] [Abstract][Full Text] [Related]
5. Correlation between the diversity of vaginal microbiota and the risk of high-risk human papillomavirus infection.
Chao XP; Sun TT; Wang S; Fan QB; Shi HH; Zhu L; Lang JH
Int J Gynecol Cancer; 2019 Jan; 29(1):28-34. PubMed ID: 30640680
[TBL] [Abstract][Full Text] [Related]
6. Changes of vaginal microbiota during cervical carcinogenesis in women with human papillomavirus infection.
So KA; Yang EJ; Kim NR; Hong SR; Lee JH; Hwang CS; Shim SH; Lee SJ; Kim TJ
PLoS One; 2020; 15(9):e0238705. PubMed ID: 32941440
[TBL] [Abstract][Full Text] [Related]
7. Vaginal dysbiosis and the risk of human papillomavirus and cervical cancer: systematic review and meta-analysis.
Brusselaers N; Shrestha S; van de Wijgert J; Verstraelen H
Am J Obstet Gynecol; 2019 Jul; 221(1):9-18.e8. PubMed ID: 30550767
[TBL] [Abstract][Full Text] [Related]
8. Immune activation in cervical neoplasia: cross-sectional association between plasma soluble interleukin 2 receptor levels and disease.
Hildesheim A; Schiffman MH; Tsukui T; Swanson CA; Lucci J; Scott DR; Glass AG; Rush BB; Lorincz AT; Corrigan A; Burk RD; Helgesen K; Houghten RA; Sherman ME; Kurman RJ; Berzofsky JA; Kramer TR
Cancer Epidemiol Biomarkers Prev; 1997 Oct; 6(10):807-13. PubMed ID: 9332763
[TBL] [Abstract][Full Text] [Related]
9. Deciphering the complex interplay between microbiota, HPV, inflammation and cancer through cervicovaginal metabolic profiling.
Ilhan ZE; Łaniewski P; Thomas N; Roe DJ; Chase DM; Herbst-Kralovetz MM
EBioMedicine; 2019 Jun; 44():675-690. PubMed ID: 31027917
[TBL] [Abstract][Full Text] [Related]
10. HPV and Other Microbiota; Who's Good and Who's Bad: Effects of the Microbial Environment on the Development of Cervical Cancer-A Non-Systematic Review.
Läsche M; Urban H; Gallwas J; Gründker C
Cells; 2021 Mar; 10(3):. PubMed ID: 33807087
[TBL] [Abstract][Full Text] [Related]
11. Human papillomavirus and cervical cancer in the microbial world: exploring the vaginal microecology.
Zhang Z; Ma Q; Zhang L; Ma L; Wang D; Yang Y; Jia P; Wu Y; Wang F
Front Cell Infect Microbiol; 2024; 14():1325500. PubMed ID: 38333037
[TBL] [Abstract][Full Text] [Related]
12. Vaginal microbiota and personal risk factors associated with HPV status conversion-A new approach to reduce the risk of cervical cancer?
Yang Z; Zhang Y; Stubbe-Espejel A; Zhao Y; Liu M; Li J; Zhao Y; Tong G; Liu N; Qi L; Hutchins A; Lin S; Li Y
PLoS One; 2022; 17(8):e0270521. PubMed ID: 35944043
[TBL] [Abstract][Full Text] [Related]
13. Cervical Microbiome and Cytokine Profile at Various Stages of Cervical Cancer: A Pilot Study.
Audirac-Chalifour A; Torres-Poveda K; Bahena-Román M; Téllez-Sosa J; Martínez-Barnetche J; Cortina-Ceballos B; López-Estrada G; Delgado-Romero K; Burguete-García AI; Cantú D; García-Carrancá A; Madrid-Marina V
PLoS One; 2016; 11(4):e0153274. PubMed ID: 27115350
[TBL] [Abstract][Full Text] [Related]
14. The three most common human papillomavirus oncogenic types and their integration state in Thai women with cervical precancerous lesions and carcinomas.
Aromseree S; Chaiwongkot A; Ekalaksananan T; Kongyingyoes B; Patarapadungkit N; Pientong C
J Med Virol; 2014 Nov; 86(11):1911-9. PubMed ID: 25091234
[TBL] [Abstract][Full Text] [Related]
15. Features of the cervicovaginal microenvironment drive cancer biomarker signatures in patients across cervical carcinogenesis.
Łaniewski P; Cui H; Roe DJ; Barnes D; Goulder A; Monk BJ; Greenspan DL; Chase DM; Herbst-Kralovetz MM
Sci Rep; 2019 May; 9(1):7333. PubMed ID: 31089160
[TBL] [Abstract][Full Text] [Related]
16. Role of Immunity and Vaginal Microbiome in Clearance and Persistence of Human Papillomavirus Infection.
Ntuli L; Mtshali A; Mzobe G; Liebenberg LJ; Ngcapu S
Front Cell Infect Microbiol; 2022; 12():927131. PubMed ID: 35873158
[TBL] [Abstract][Full Text] [Related]
17. Comparison of vaginal microbiota sampling techniques: cytobrush versus swab.
Mitra A; MacIntyre DA; Mahajan V; Lee YS; Smith A; Marchesi JR; Lyons D; Bennett PR; Kyrgiou M
Sci Rep; 2017 Aug; 7(1):9802. PubMed ID: 28852043
[TBL] [Abstract][Full Text] [Related]
18. A cohort study of the risk of cervical intraepithelial neoplasia grade 2 or 3 in relation to papillomavirus infection.
Koutsky LA; Holmes KK; Critchlow CW; Stevens CE; Paavonen J; Beckmann AM; DeRouen TA; Galloway DA; Vernon D; Kiviat NB
N Engl J Med; 1992 Oct; 327(18):1272-8. PubMed ID: 1328880
[TBL] [Abstract][Full Text] [Related]
19. The role of interleukin 10 in human papilloma virus infection and progression to cervical carcinoma.
Berti FCB; Pereira APL; Cebinelli GCM; Trugilo KP; Brajão de Oliveira K
Cytokine Growth Factor Rev; 2017 Apr; 34():1-13. PubMed ID: 28365229
[TBL] [Abstract][Full Text] [Related]
20. Vaginal microbiota and HPV clearance: A longitudinal study.
Shi W; Zhu H; Yuan L; Chen X; Huang X; Wang K; Li Z
Front Oncol; 2022; 12():955150. PubMed ID: 36353544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
